Samreen Ahmed, FRCP, MD, MBBS, MSc (onc), University Hospitals of Leicester, Leicester, UK, comments on her contribution at the European Lung Cancer Congress (ELCC) 2023 in Copenhagen, Denmark, discussing the control of brain metastases that commonly arise in patients with mutationally-driven lung cancer. This interview took place at ELCC 2023 in Copenhagen, Denmark.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
